BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12532086)

  • 21. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
    Hay DW
    Chest; 1997 Feb; 111(2 Suppl):35S-45S. PubMed ID: 9042025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
    Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
    Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
    Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cysteinyl-leukotrienes: important mediators in asthma].
    Louis R; Neven I; Quadvlieg V; Bettiol J; Radermecker M
    Rev Med Liege; 1997 Sep; 52(9):598-602. PubMed ID: 9441344
    [No Abstract]   [Full Text] [Related]  

  • 27. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
    Claesson HE; Dahlén SE
    J Intern Med; 1999 Mar; 245(3):205-27. PubMed ID: 10205583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antileukotriene treatment in children with asthma--new patents.
    Stelmach I; Grzelewski T
    Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):202-11. PubMed ID: 19076010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antileukotriene drugs: a new treatment for asthma].
    Armetti L; Nicosia S
    Boll Chim Farm; 1999 Dec; 138(11):599-605. PubMed ID: 10765473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
    Hsu CH; Hu CM; Lu KH; Yang SF; Tsai CH; Ko CL; Sun HL; Lue KH
    Pediatr Neonatol; 2012 Aug; 53(4):235-44. PubMed ID: 22964281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
    Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study on bronchial asthma and leukotriene antagonists].
    Yokoyama A
    Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2656-61. PubMed ID: 15658499
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic advances: leukotriene antagonists for the treatment of asthma.
    Misson J; Clark W; Kendall MJ
    J Clin Pharm Ther; 1999 Feb; 24(1):17-22. PubMed ID: 10319903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of leukotrienes and leukotriene receptor antagonists in asthma.
    Jones TR; Rodger IW
    Pulm Pharmacol Ther; 1999; 12(2):107-10. PubMed ID: 10373391
    [No Abstract]   [Full Text] [Related]  

  • 37. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S; McIvor RA
    Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine monophosphate bronchial provocation and the actions of asthma therapy.
    Lee DK; Gray RD; Lipworth BJ
    Clin Exp Allergy; 2003 Mar; 33(3):287-94. PubMed ID: 12614440
    [No Abstract]   [Full Text] [Related]  

  • 39. Cysteinyl leukotrienes in asthma: old mediators up to new tricks.
    Hay DW; Torphy TJ; Undem BJ
    Trends Pharmacol Sci; 1995 Sep; 16(9):304-9. PubMed ID: 7482995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.